Technique uses 3-D weaving to grow a living hip replacement
With a goal of treating worn, arthritic hips without extensive surgery to replace them, scientists have programmed stem cells to grow new cartilage on a 3-D template shaped like the ball of a hip joint. What’s more, using gene therapy, they have activated the new cartilage to release anti-inflammatory molecules to fend off a return of arthritis.
The technique, demonstrated in a collaborative effort between Washington University School of Medicine in St. Louis and Cytex Therapeutics Inc. in Durham, N.C., is described July 18 in Proceedings of the National Academy of Sciences.
The discovery one day may provide an alternative to hip-replacement surgery, particularly in younger patients. Doctors are reluctant to perform such operations in patients under age 50 because prosthetic joints typically last for less than 20 years. A second joint-replacement surgery to remove a worn prosthetic can destroy bone and put patients at risk for infection.
“Replacing a failed prosthetic joint is a difficult surgery,” said Farshid Guilak, PhD, a professor of orthopedic surgery at Washington University. “We’ve developed a way to resurface an arthritic joint using a patient’s own stem cells to grow new cartilage, combined with gene therapy to release anti-inflammatory molecules to keep arthritis at bay. Our hope is to prevent, or at least delay, a standard metal and plastic prosthetic joint replacement.”
The technique uses a 3-D, biodegradable synthetic scaffold that Guilak and his team developed. The scaffold, molded into the precise shape of a patient’s joint, is covered with cartilage made from the patient’s own stem cells taken from fat beneath the skin. The scaffold then can be implanted onto the surface of an arthritic hip, for example. Resurfacing the hip joint with “living” tissue is designed to ease arthritis pain, and delay or even eliminate the need for joint-replacement surgery in some patients.
Additionally, by inserting a gene into the newly grown cartilage and activating it with a drug, the gene can orchestrate the release of anti-inflammatory molecules to fight a return of arthritis, which usually is what triggers such joint problems in the first place.
“When there is inflammation, we can give a patient a simple drug, which activates the gene we’ve implanted, to lower inflammation in the joint,” said Guilak, also a professor of developmental biology and of biomedical engineering. “We can stop giving the drug at any time, which turns off the gene.”
That gene therapy is important, he explained, because when levels of inflammatory molecules rise in a joint, the cartilage is destroyed and pain increases. By adding gene therapy to the stem cell and scaffold technique, Guilak and his colleagues believe it will be possible to coax patients’ joints to fend off arthritis and function better for a longer time.
The 3-D scaffold is built using a weaving pattern that gives the device the structure and properties of normal cartilage. Franklin Moutos, PhD, vice president of technology development at Cytex, explained that the unique structure is the result of approximately 600 biodegradable fiber bundles woven together to create a high-performance fabric that can function like normal cartilage.
“As evidence of this, the woven implants are strong enough to withstand loads up to 10 times a patient’s body weight, which is typically what our joints must bear when we exercise,” Moutos said.
Currently, there are about 30 million Americans who have diagnoses of osteoarthritis, and data suggest that the incidence of osteoarthritis is on the rise. That number includes many younger patients — ages 40 to 65 — who have limited treatment options because conservative approaches haven’t worked and they are not yet candidates for total joint replacement because of their ages.
Bradley Estes, PhD, vice president of research and development at Cytex, noted, “We envision in the future that this population of younger patients may be ideal candidates for this type of biological joint replacement.”
Guilak, who also is the director of research at Shriners Hospitals for Children — St. Louis, and co-director of the Washington University Center of Regenerative Medicine, has been collaborating with Cytex on this research. The scientists have tested various aspects of the tissue engineering in cell culture, and some customized implants already are being tested in laboratory animals. He said if all goes well, such devices could be ready for safety testing in humans in three to five years.
The Latest on: Stem cells to grow new cartilage
via Google News
The Latest on: Stem cells to grow new cartilage
- These sea slugs cut off their own heads and grow an entirely new bodyon March 8, 2021 at 2:55 pm
Two species of sacoglossan sea slugs aren't most animals. A team of researchers observed sea slugs that severed their own heads and then regrew their bodies complete with hearts and other internal ...
- Noveome Biotherapeutics, Inc. Makes New Appointment to Board of Directorson March 8, 2021 at 11:30 am
Noveome Biotherapeutics, Inc., a clinical stage biopharmaceutical company focused on developing next-generation biologics for the restoration of cellular integrity of damaged tissues, has appointed.
- Cell Therapy for Cartilage Regeneration Gets a Boost With Hyaluronic Acid Enriched Chondrocytes in a 3D Tissue Engineering Platformon March 8, 2021 at 12:21 am
Hyaluronic acid enriched, lab-grown chondrocytes to improvise ACI & MACI cell therapy for cartilage regeneration; A feat by Japanese orthopedicians ...
- Global Knee Cartilage Repair Market Sees Lucrative Growth Prospects in Vericel Announcement of New Implant, says Fortune Business Insightson March 3, 2021 at 6:02 pm
The global “ knee cartilage repair market ” is currently witnessing increasing investment towards research and development. In a report, titled “Knee Cartilage Repair Market Size, Share and Global ...
- Stem Cell Therapy in Wisconsin with Delo Sports Medicine and Interventional Orthopedicson March 2, 2021 at 8:19 am
There’s a growing trend of regenerative medicine and in healing. Dr. Marjorie Delo of Delo Sports Medicine and Interventional Orthopedics spoke to Local 5 Live with details on how they ...
- NSAIDs to Treat Arthritic Canines Through 2028; Stem Cell Therapies to Invigorate Canine Arthritis Treatment Marketon March 1, 2021 at 1:13 pm
The global Canine Arthritis Treatment Market is expected to reach US$ 3051.8 Mn by 2028, growing at a moderate ...
- How plant stem cells renew themselves—a cytokinin storyon February 25, 2021 at 11:01 am
The mechanism by which the plant hormone cytokinin controls cell division has been discovered—a breakthrough that significantly improves our understanding of how plants grow.
- Controversial Stem Cell Therapy Has Helped Repair Injured Spinal Cords in 13 Patientson February 24, 2021 at 9:36 pm
Spinal cord injuries are sustained by hundreds of thousands of people every year, with many patients experiencing a significant and often permanent loss of movement and physical sensation resulting ...
- Stem cell injections in knee osteoarthritis: a systematic review of the literatureon February 2, 2021 at 4:00 pm
Objective Stem cell injection for knee osteoarthritis (KOA) is an emerging new therapy, and we aimed to review its evidence ... As the amount of published trials within the field of stem cell research ...
- Stem cells programmed to grow cartilage inside bodyon February 19, 2014 at 10:18 am
Scientists have used gene therapy to direct stem cells to grow new cartilage inside a living body. Performing tissue repair with stem cells typically requires applying copious amounts of growth ...
via Bing News